I published apricot on March 20, 2018 to prevent thrombosis and reverse? , reader nestser left a message on 2025-6-28:
I would like to ask the professor, there is a Schwabe Group, the brand of silver apricot extract sold in English is Tebonin, and in the mainland, it is called Jinnado. The number is known as the extraction patent, which is probably just a careless health product, right?Schwabe Group is a herbal medicine and health care company founded by the Schwabe family in Germany, and Tebonin is their signature product, apricot supplement. As for whether Tebonin is a scammer health product, I will discuss the overall treatment of silver apricot supplement.
The most commonly praised effect of aphrodisiac supplement is to prevent or treat dementia. I have already posted about this question that the elderly are stunned. Can they prevent and can they prevent dementia?
In order to encourage the medical community to engage in "non-mainstream" medical research, the US government established the National Center for Complementary and Integrative Health in 1998. The so-called "non-mainstream" mainly refers to research on herbal medicine. Therefore, it is conceivable that this research center will not favor herbicide research. However, with regard to the apricot supplement, it is so ruthlessly said:
1. Apricot leaves (usually in the form of extracts) are the most commonly used form of apricots. Apricots are promoted as dietary supplements for a variety of diseases, including anxiety disorders, heart disease, cognitive impairment and dementia, diabetes, pre-symptoms (PMS), schizophrenia and erectile dysfunction. In addition, 陈光 is also promoted as being able to enhance the awareness of healthy people.2. There have been many studies on the health effects of the use of apricots. However, apricot has not been proven to be effective for any disease that has been studied.
3. In three large studies of elderly people with normal cognitive function or mild cognitive impairment, supplementation of apricot extract did not reduce the risk of dementia. One of the studies was the "GEM" study funded by the National Center for Replenishment and Integration of Health and the National Institute of Aging. In this study, more than 3,000 elderly people with normal cognitive function or mild cognitive impairment were randomly assigned to take apricot supplement or consolation agents for an average of 6 years. There was no difference between the apricot and the pamperer group in terms of the rate of participants suffering from any type of dementia or Alzheimer's disease.
4. Apricots are not beneficial for preventing heart disease, treating hypertension, or relieving symptoms of erectile dysfunction or polydehyde sclerosis.
The well-known Maego clinic also said that research does not support the use of apricot to prevent or reduce dementia or decreased awareness.
Harvard University also said: Silver Apricot Leaf Extract is sold as a supplement, and one of its main selling points is to enhance memory. However, like other brain supplements, scientific evidence does not support this statement.
Schwabe Group's silver leaf extract has a patent name called EGb761. Most studies on silver apricot leaf extract use this so-called "standard silver apricot leaf extract".
For EGb761, there are two large-scale combined analytical studies published in 2024 and 2025:
2024: EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years? (EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years?).
This study analyzed all randomly controlled clinical studies on the treatment of dementia by EGb761 from 2006 to 2023, and the conclusion was that the study results did not consistently prove the clinical utility of EGb761, and the increase in cognitive and neural estimation scores may not necessarily translate into intentional clinical results for dementia patients. The question "What have we learned in the past 18 years?" comes out, and the answer is: I haven't learned much. So the question that comes up is: how long should we continue to come up with the same conclusion, continue to invest time and financially to copy these results? Research strategies should be improved, policy formulation should be formulated, and practical treatment of neural cognitive impairments should be promoted.
2025: Ginkgo biloba leaf extract EGb 761® for the treatment of various diseases: Overview of systematic reviews (Silver leaf extract EGb 761® for the treatment of multiple diseases: Overview of systematic reviews).
This study is from the Department of Integrated Medicine at Duisburg-Essen University in Germany. Since it is "Germany" from Schwabe Group and is closely related to health care products, this study evaluates EGb761 even more unusual.
It analyzed all systematic reviews of all diseases of EGb761 (126 articles in total) as of January 30, 2025, and the conclusion is: EGb 761® has been discussed in many remarks, especially in neurologic disorders, and has been proven to be safe in many systematic review reports.. But because these systematic review reports are of poor quality, their results must be treated with caution.
So, for the readers’ questions, “Is Tebonin a cheating health product?” I can only say: “It cannot be said to be cheating, but after 60 years of scientific research, silver apricot health product has not been proven to be effective for any disease that has been studied.”
Original text: Is silver apricot a careless health product?Responsible editor: Gu Zihuan